FUJIFILM Biotechnologies launches purification technology for biologics
ShunzymeX leverages a proprietary protease to streamline purification
ShunzymeX leverages a proprietary protease to streamline purification
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
It is also approved for?AIDS-related Kaposi sarcoma?after failure of highly active antiretroviral therapy, as well as for HIV-negative adult patients with Kaposi sarcoma
A next-generation, cell-based immunotherapy, CAR-T therapy engineers a patient’s own immune cells to detect and destroy cancer
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
Merck emphasized the broader significance of the findings
This study evaluated a difficult-to-treat Crohn's disease patient population
Subscribe To Our Newsletter & Stay Updated